A 7-Cloro-2-metilamino-5-fenil-3H-1,4-benzodiazepina 4-ossido CEP of the European Pharmacopoeia monograph is often referred to as a 7-Cloro-2-metilamino-5-fenil-3H-1,4-benzodiazepina 4-ossido Certificate of Suitability (COS). The purpose of a 7-Cloro-2-metilamino-5-fenil-3H-1,4-benzodiazepina 4-ossido CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 7-Cloro-2-metilamino-5-fenil-3H-1,4-benzodiazepina 4-ossido EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 7-Cloro-2-metilamino-5-fenil-3H-1,4-benzodiazepina 4-ossido to their clients by showing that a 7-Cloro-2-metilamino-5-fenil-3H-1,4-benzodiazepina 4-ossido CEP has been issued for it. The manufacturer submits a 7-Cloro-2-metilamino-5-fenil-3H-1,4-benzodiazepina 4-ossido CEP (COS) as part of the market authorization procedure, and it takes on the role of a 7-Cloro-2-metilamino-5-fenil-3H-1,4-benzodiazepina 4-ossido CEP holder for the record. Additionally, the data presented in the 7-Cloro-2-metilamino-5-fenil-3H-1,4-benzodiazepina 4-ossido CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 7-Cloro-2-metilamino-5-fenil-3H-1,4-benzodiazepina 4-ossido DMF.
A 7-Cloro-2-metilamino-5-fenil-3H-1,4-benzodiazepina 4-ossido CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 7-Cloro-2-metilamino-5-fenil-3H-1,4-benzodiazepina 4-ossido CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 7-Cloro-2-metilamino-5-fenil-3H-1,4-benzodiazepina 4-ossido suppliers with CEP (COS) on PharmaCompass.